Incidence of Lenkemia in Atomic Bomb Survivors Belonging to a Fixed Cohort in Hiroshima and Nagasaki, 1950-71 : Radiation dose, years after exposure, age at exposure, and type of leukemia
スポンサーリンク
概要
- 論文の詳細を見る
The leukemogenic effect of atomic radiation was examined in relation to age at the time of the bomb (ATB), calendar time, and type of leukemia over the period 1950-71. Confirmed cases of leukemia in the Leukemia Registry, a fixed cohort of 109,000 subjects and the T65 dose calculations provided the basis for the analysis. Calendar time was divided into three periods, 5-10, 10-15, and 15-26 years after the bombs. The larger the exposure dose and the younger the age ATB, the greater was the effect in the early period and the more rapid was the decline in risk in subsequent years. In the oldest group, aged 45 or over ATB, the increase in rlsk appeared later and was sustained in the period 1960-71. Chronic granulocytic leukemla contributed substantially to the total leukemogenic effect initially but made little contribution after 1955. Sensitivity to the leukemogenic effect of atomic radiation not only depended on age ATB but its expression varied by type of leukemia and with time after exposure. Although the effect of atomic radiatlon on the incidence of leukemia in the atomic survivors is now greatly reduced and apparently on the wane, in the period 1966-71 the incidence was still greater than expected, especially in Hiroshima. In the Nagasaki sample, no case of leukemia was observed among the high-dose subjects from July 1966 to the end of 1971. In the study of radiation leukemogenesis in man, continued surveillance of atomic bomb survivors plays a vital role.
- 日本放射線影響学会の論文
著者
-
市丸 道人
長崎大学医学部原研内科教室
-
石丸 寅之助
放射性影響研究所疫学統計室
-
BELSKY JOSEPH
Division of Medicine. The Community Health Center Danbury Hospital and the former Chief of Departmen
-
Belsky Joseph
Division Of Medicine. The Community Health Center Danbury Hospital And The Former Chief Of Departmen
-
市丸 道人
長崎大学医学部内科学第二教室
関連論文
- 急性白血病に併発する細菌感染症の治療--CFX,AMK,TIPC,LCMによる24時間持続点滴法について
- 末期患者の治療 (白血病)
- 癌と止血障害--とくにDICとの関係について (血液凝固障害とその臨床特集)
- 白血病治療におけるステロイドホルモンの適応と使い方 (ステロイドホルモン療法特集--その適応と使い方)
- 輸血とATLA抗体
- 白血病細胞の病理 : とくにATL(成人T細胞白血病)細胞を中心に(特別講演, 第22回日本臨床細胞学会秋期大会)
- 長崎市原爆被爆者の血液學的研究 (第4報)
- Human T-lymphotropic virus type-I (HTLV-I)持続感染者のIgM抗adult T-cell leukemia associated antigens (ATLA)抗体について
- ATLの前白血病状態とHTLV-I
- 白血病 (臨床治療の展望)
- 成人T細胞性白血病(ATL)の臨床 (白血病)
- 広島・長崎の被爆者における多発性骨髄腫,1950-76年--骨髄吸収放射線量との関係
- non-Hodgkinリンパ腫の臨床と病理--T2 cell malignancy (免疫系腫瘍--Hodgkin病とnon-Hodgkinリンパ腫) -- (non-Hodgkinリンパ腫)
- 原爆後障害としての造血器異常の推移 (第21回原子爆弾後障害研究会講演集) -- (長崎における原爆被爆者の健康と疾病の動態(シンポジウム))
- 放射線と白血病
- 広島・長崎原爆被爆者の白血病発生率と中性子線及びガンマ線との線量反応関係,白血病の病型別,1950-71年
- Incidence of Lenkemia in Atomic Bomb Survivors Belonging to a Fixed Cohort in Hiroshima and Nagasaki, 1950-71 : Radiation dose, years after exposure, age at exposure, and type of leukemia
- Leukemia and Related Disorders
- T cell悪性リンパ腫の臨床
- 気管支喘息および薬物過敏症の抗原および薬物によるリンパ球幼若化現象